Georgia Institute of Technology

What Georgia Institute of Technology does

Georgia Institute of Technology, founded in 1885 and part of the University System of Georgia, operates the Office of Technology Licensing (OTL) as its central technology commercialization arm. The OTL manages intellectual property created by Georgia Tech faculty, staff, and students, connecting research innovations with industry partners through licensing agreements and startup formation. The institution serves researchers seeking commercialization support, entrepreneurs building startups on GT technology, and industry partners licensing proprietary IP across medical devices, drug delivery, defense, and materials science.

The OTL's portfolio includes several notable proprietary technologies. Precision TAVI is an FDA-approved AI-driven predictive modeling software that creates patient-specific digital twins for cardiac valve replacement surgery planning; it was commercialized through DASI Simulations, co-founded by inventor Dr. Lakshmi Prasad Dasi, and is deployed in dozens of U.S. hospitals. Additional technologies include a hydrophobic ion complex for low-cost intracellular drug delivery (Dr. Julie Champion), recombinant antibodies targeting misfolded myocilin for glaucoma (Dr. Raquel L. Lieberman), and long-range X-ray imaging algorithms developed under DARPA's XENA program with RTX's BBN Technologies. In 2025, the OTL issued 124 U.S. patents (20% YoY increase) and recorded 464 new invention disclosures (31% increase, the highest in institutional history).

The OTL generates revenue through licensing royalties, milestone payments, license fees, and equity stakes in affiliated startups. The commercialization ecosystem extends beyond OTL to include the Advanced Technology Development Center (ATDC), VentureLab, Biolocity, CREATE-X, Velocity Startups, Georgia Manufacturing Extension Partnership, and Enterprise Innovation Institute. Since 1980, ATDC startup graduates have attracted over $6.2 billion in investment and generated more than $14 billion in revenue in Georgia. Recent strategic priorities include expansion into Augusta, Georgia for medical device innovation and integration of AI predictive modeling across additional surgical specialties.

Name

Georgia Institute of Technology

Legal name

Georgia Institute of Technology

Website

https://licensing.research.gatech.edu

Company type

Private

Founded year

1885

Operating status

Operating

Headcount range

11–50 employees

Short description

Georgia Institute of Technology operates the Office of Technology Licensing, commercializing university research through licensing agreements, startup formation, and industry partnerships. OTL manages IP across medical devices, drug delivery, defense, and materials science, with FDA-approved AI products like Precision TAVI.

Ownership category

akta.pro rank

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Licensing Royalties: OTL negotiates licensing agreements with companies and startups to commercialize Georgia Tech technologies. Terms include fees, milestones, royalties, and/or equity to support sustainable growth.
2. Technology Licensing Fees: Revenue generated from licensing agreements including technology marketing, term sheets, license negotiations, and compliance monitoring.
3. Startup Equity: OTL supports formation of Georgia Tech-affiliated startup companies. Inventors may leverage programs across the commercialization ecosystem. Hundreds of companies have been formed based on GT innovations.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

The Office of Technology Licensing (OTL) delivers resources and support to demystify the commercialization process, seamlessly moving innovative intellectual property (IP) to market. OTL manages invention disclosures, files patents, markets technologies to industry partners through non-confidential summaries, negotiates licensing agreements (fees, milestones, royalties, equity), and supports formation of Georgia Tech-affiliated startup companies. The office issued 124 U.S. patents in 2025 and reported a 210% increase in technologies licensed.

Product overview

Georgia Institute of Technology operates the Office of Technology Licensing (OTL), which serves as the university's technology commercialization hub. The OTL platform provides technology licensing services, managing intellectual property from disclosure through patent filing, marketing, and licensing to industry partners or startup companies. Notable products include Precision TAVI, an FDA-approved AI predictive modeling software for cardiac valve replacement surgery planning that creates patient-specific digital twins. The ecosystem includes multiple startup support programs (VentureLab, Biolocity, CREATE-X, Quadrant-i, Velocity Startups) and a structured 6-step licensing process from invention disclosure to license compliance. The office reported 124 U.S. patents issued in 2025 with a 210% increase in technologies licensed year-over-year.

Differentiator

Problem solved

Functional benefit

Products and services

• Precision TAVI

Quantifiable outcome

• 124 U.S. patents issued in 2025 (20% increase YoY)
• +5 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Augusta UniversitycoreStrategic or Co-development Partner · 1 February 2026Georgia Institute of Technology and Augusta University partnered to boost the medical device innovation ecosystem in Augusta, Georgia. The partnership aims to address gaps in commercialization, regulatory navigation, and funding to help researchers and entrepreneurs bring medical devices to market, leveraging Augusta's existing healthcare infrastructure including five hospitals and the Medical College of Georgia.
• Georgia Manufacturing Extension PartnershipcoreStrategic or Co-development PartnerGeorgia Manufacturing Extension Partnership is leading the collaboration with Augusta University and Georgia Tech to boost Augusta's medical device innovation ecosystem, providing regulatory guidance and manufacturing support.
• Advanced Technology Development Center (ATDC)coreStrategic or Co-development PartnerATDC leads the collaboration with Augusta University and Georgia Tech to boost Augusta's medical device innovation ecosystem, providing commercialization support. Since 1980, ATDC's startup graduates have attracted more than $6.2 billion in investment and generated over $14 billion in revenue in Georgia.
• RTX's BBN TechnologiescoreStrategic or Co-development PartnerRTX's BBN Technologies was awarded a contract by DARPA under its X-ray Extreme-range Non-imaging Analysis (XENA) program. The BBN-led team includes Georgia Institute of Technology, with work conducted in Cambridge, Massachusetts and Atlanta, Georgia to develop long-range X-ray imaging algorithms.
• Georgia Life SciencesminorStrategic or Co-development PartnerGeorgia Life Sciences designated Augusta as a BioReady Gold community, supporting the medical device innovation ecosystem initiative led by Georgia Tech and Augusta University.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• University of Michigan Innovation Partnerships: U-M Innovation Partnerships runs tech transfer at a large public research university with strong engineering and biomedical output — structurally similar to Georgia Tech as a public R1 institution. Both serve large faculty populations, manage equity in startup spinouts, and engage large industry licensees.
• MIT Technology Licensing Office: MIT TLO manages intellectual property from one of the world's leading engineering and science institutions, handling invention disclosures, patenting, and licensing to industry and startups. Like Georgia Tech, MIT is engineering-heavy and produces inventions spanning software, biomedical devices, materials, and defense.
• University of Pennsylvania Center for Innovation: Penn PCI runs technology transfer for the University of Pennsylvania, a research-intensive institution with strong biomedical and engineering output. It is comparable to Georgia Tech OTL in mission, scale, and customer base, and one of GT's licensing team members (Gennaro Gama) previously worked at UPenn's tech transfer office.
• Columbia Technology Ventures: Columbia Technology Ventures is the technology transfer office for Columbia University, ranked among the top US TLOs by licensing revenue. It is comparable to Georgia Tech OTL in serving a research-intensive university with significant life sciences and engineering output, and is a direct competitor for industry licensing relationships.
• Stanford University Office of Technology Licensing: Stanford OTL is the gold-standard university technology licensing office, managing patent prosecution, marketing, and licensing of inventions from Stanford faculty. It is directly comparable to Georgia Tech OTL in mission and operating model, and GT's current licensing director Mary Albertson spent 26 years there, making it the closest functional peer.
• Duke Office of Licensing & Ventures: Duke OLV manages Duke University's technology commercialization, with significant biomedical and engineering licensing activity. It is comparable to Georgia Tech OTL in handling invention disclosures, patents, and licensing across life sciences and engineering domains.
• Purdue Research Foundation: Purdue Research Foundation manages technology transfer and commercialization for Purdue University, another leading engineering-focused public university. It is comparable in operating model and customer base to Georgia Tech OTL, with similar strengths in engineering, life sciences, and defense-adjacent IP.
• Johns Hopkins Technology Ventures: JHTV handles technology commercialization for Johns Hopkins, a research university with deep life sciences and medical device output. It is comparable to Georgia Tech OTL in mission, structure, and customer base (industry licensors and startup formation), particularly given GT's emerging medical-device focus.
• Carnegie Mellon University Technology Transfer: CMU's Office of Technology Transfer handles IP commercialization for a leading engineering and computer science university. It is highly comparable to Georgia Tech OTL given overlapping strengths in AI, software, robotics, and translational engineering research feeding the licensing pipeline.

Others

• AUTM (Association of University Technology Managers): AUTM is the international professional association for university technology transfer offices, including Georgia Tech OTL. It is not a direct competitor but is the industry body that defines standards, collects benchmarking data, and where GT's licensing director Mary Albertson served as President.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/GaTechOTL
• YouTubeyoutube.com/channel/UCt7qoJj957a4cZdtEh-oU9g/videos
• LinkedInlinkedin.com/company/georgia-tech-office-of-technology-licensing

Revenue estimate

Valuation estimate

Number of profiles

Profiles25 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Georgia Institute of Technology